⌘K

Login Start Free

Home/Filings/4/0001209191-16-098329

4//SEC Filing

RXi Pharmaceuticals Corp 4

Accession 0001209191-16-098329

$PHIOCIK 0001533040operating

View on SEC.gov Company Profile

Filed

Feb 11, 7:00 PM ET

Accepted

Feb 12, 8:47 PM ET

Size

5.4 KB

Accession

0001209191-16-098329

Insider Transaction Report

Form 4

Period: 2016-02-10

RXi Pharmaceuticals CorpRXII

Chief Development Officer

Transactions

Award
Stock option (right to buy)
2016-02-10+66,000→ 66,000 total
Exercise: $0.29Exp: 2026-02-10→ Common stock (66,000 underlying)

Footnotes (1)

[F1]The stock option vests in equal monthly installments over four years beginning on the first monthly anniversary of the grant date.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

RXi Pharmaceuticals Corp

CIK 0001533040

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0001533040

Filing Metadata

Form type: 4
Filed: Feb 11, 7:00 PM ET
Accepted: Feb 12, 8:47 PM ET
Size: 5.4 KB

View on SEC.gov